- •
Cutaneous squamous cell carcinoma (cSCC) is a common skin cancer that presents as a scaly, red, or bleeding lesion on sun-exposed areas.
- •
UV exposure, fair skin, and immunosuppression increase incidence of cSCC.
- •
Recurrence and metastasis are associated with tumor diameter greater than 2 cm, depth greater than 2 mm or beyond subcutaneous fat, extensive or large-caliber perineural involvement, and poor differentiation on histopathology.
- •
AJCC 8 is used for TNM staging for cSCC of the head and neck.
Cutaneous Squamous Cell Carcinoma
Section snippets
Key points
Incidence and epidemiology
Cutaneous squamous cell carcinoma (cSCC) is the second most common nonmelanoma skin cancer. It accounts for 20% of skin cancer and results in 1 million cases in the United States each year resulting in up to 9000 estimated deaths.1, 2, 3, 4
Depending on the latitude, the incidence of cSCC ranges from 5 to 499 per 100,000 patients.5, 6, 7, 8 The lifetime risk of developing SCC is 14–20% in a non-hispanic white population in the United States.9, 10 This number continues to increase annually with
Clinical presentation
cSCC presents as a red scaly plaque, typically in sun-exposed areas. Lesions are typically solitary (Fig. 1A); however, they rarely can present as multiple “in transit” metastases (Fig. 1B).
Work-up
Diagnosis is made by a skin biopsy deep enough to allow the pathologist to comment on depth of invasion, perineural or lymphovascular invasion, differentiation, and connection to the overlying epidermis.12 Local lymph nodes and parotid when appropriate should be evaluated by clinical examination and should be sampled if clinically involved.13 The value of sentinel lymph node biopsy in cSCC without clinically apparent lymph nodes is currently unknown.14, 15, 16, 17 The patient should also be
Histopathology
On histopathology, cSCC differentiation may vary from well to poorly differentiated. Well-differentiated tumors exhibit interconnecting follicular infundibular type squamous epithelium. Mitosis may be rare or absent. Poor differentiation indicates that it is difficult to determine a keratinocyte lineage (Fig. 2).19, 20
Risk factors
The most significant risk factors resulting in cSCC include UV exposure, older age, fair skin (Fitzpatrick skin types I-III), and immunosuppression. UV (primarily UV-B) from the sun or tanning beds induces skin cancer by causing DNA damage.21, 22, 23, 24, 25 The incidence of SCC doubles with each 8° to 10° in latitude.26, 27 Skin types that burn after UV exposure (related to Fitzpatrick skin type) are predisposed to developing cSCC.28
Genetics
cSCC carries more mutations than other common malignancies, with more than four times the mutation rates in melanoma.41 Tumor protein 53 (TP53),42 cyclin-dependent kinase inhibitor 2A mutations (CDKN2A), Ras mutations, and mutations of Notch homolog 1 are involved in cSCC carcinogenesis.41, 43 Genetic mutations found to be differentially expressed in cSCC include CXCL8 (IL8), MMP1, HIF1A, ITGA6, and ITGA2.20, 44
Mortality
Although most cSCC are treated locally with no sequelae, a small subset result in tumor-specific mortality. In the United States, the annual disease-specific mortality is estimated to be 1.5% to 2% with up to 4% mortality rates reported in other countries; 5604 to 12,572 people with cSCC developed nodal metastases with an estimated 9000 deaths.2, 45 Factors associated with local recurrence and metastases are listed in Table 1.
American Joint Committee on Cancer-8
In October 2016, the American Joint Committee on Cancer (AJCC) introduced the eighth edition of its cancer staging systems.62 The AJCC-8 staging system classifies cSCC of the head and neck by local tumor burden (T), nodal status (N), and metastatic disease (M).61, 63 Stage T1 are tumors less than 2 cm. T2 are tumors 2–3.9 cm. T3 tumors are ≥4 cm or with minor bone erosion or large caliber perineural invasion or deep invasion >6 mm. T4a tumors invade to cortical bone or marrow and T4b invade the
Treatment
cSCC is stratified into low risk or high risk. Guidelines are available to help guide treatment including those by the National Comprehensive Cancer Network (NCCN)13 and the American Academy of Dermatology (AAD) guidelines (Table 2).12
There are two main types of margin analysis commonly used for surgically excised cSCC: sectional assessment used in standard excision, and complete circumferential peripheral and deep margin assessment (CCPDMA). Sectional assessment describes traditional “bread
Prevention
Photoprotective measures including sunscreen application have been shown to decrease SCC by 40%.75, 76 Other measures of prevention include those aimed at managing field cancerization (large defects of DNA damaged skin): 5-fluorouracil, imiquimod, topical retinoids, diclofenac sodium, ingenol mebutate, chemotherapy wraps, photodynamic therapy, nicotinamide and acitretin or capecitabine for very high-risk, immunosuppressed patients.12
Monitoring
A patient with at least one cSCC is at risk for additional cSCC and other for skin cancers, including basal cell carcinoma and melanoma.77, 78 The 5-year probability of another non-melanoma skin cancer (NMSC) after diagnosis of a first is 40.7%, the 10 year is 59.6%, and after more than one cSCC it is 82% and 91.2%.79 After a diagnosis of local SCC, the NCCN guidelines suggest follow-up and screening every 3 to 12 months for 2 years after initial diagnosis and then every 2 years. For regional
References (81)
Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012
J Am Acad Dermatol
(2013)Analysis of risk factors determining prognosis of cutaneous squamous cell carcinoma: a prospective study
Lancet Oncol
(2008)- et al.
Incidence of cutaneous squamous cell carcinoma in coastal and inland areas of Western Sweden
Cancer Epidemiol
(2011) - et al.
Nonmelanoma skin cancer in the united states: incidence
J Am Acad Dermatol
(1994) - et al.
Incidence and trends of basal cell carcinoma and cutaneous squamous cell carcinoma: a population-based study in Olmsted County, Minnesota, 2000 to 2010
Mayo Clin Proc
(2017) - et al.
Utility of sentinel node biopsy in patients with high-risk cutaneous squamous cell carcinoma
Eur J Surg Oncol
(2015) - et al.
High-risk cutaneous squamous cell carcinoma and the emerging role of sentinel lymph node biopsy: a literature review
J Am Acad Dermatol
(2015) - et al.
The role of imaging in the management of patients with nonmelanoma skin cancer: diagnostic modalities and applications
J Am Acad Dermatol
(2017) - et al.
Increased metastasis and mortality from cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia
J Am Acad Dermatol
(2005) - et al.
Milestones in skin carcinogenesis: the biology of multistage carcinogenesis
J Invest Dermatol
(2014)
Familial skin cancer syndromes: increased risk of nonmelanotic skin cancers and extracutaneous tumors
J Am Acad Dermatol
Ultraviolet radiation induced signature mutations in photocarcinogenesis
J Investig Dermatol Symp Proc
NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesis
J Invest Dermatol
Perineural invasion in squamous cell skin carcinoma of the head and neck
Am J Surg
Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection
J Am Acad Dermatol
Incidence and clinical course of de-novo malignancies in renal allograft recipients
Eur J Surg Oncol
Skin cancer in organ transplant recipients: more than the immune system
J Am Acad Dermatol
Trends of skin cancer mortality after transplantation in the United States: 1987 to 2013
J Am Acad Dermatol
Cutaneous squamous cell carcinoma: incidence, risk factors, diagnosis, and staging
J Am Acad Dermatol
Cutaneous squamous cell carcinoma: management of advanced and high-stage tumors
J Am Acad Dermatol
Cancers in Australia attributable to exposure to solar ultraviolet radiation and prevented by regular sunscreen use
Aust N Z J Public Health
All-cause mortality in patients with basal and squamous cell carcinoma: a systematic review and meta-analysis
J Am Acad Dermatol
Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. population, 2012
JAMA Dermatol
Factors predictive of recurrence and death from cutaneous squamous cell carcinoma. A 10-year, single-institution cohort study
JAMA Dermatol
Recent trends in incidence of nonmelanoma skin cancers in the east of Scotland, 1992-2003
Br J Dermatol
Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985
Med J Aust
Invasive cutaneous squamous cell carcinoma incidence in US health care workers
Arch Dermatol Res
Prevalence of a history of skin cancer in 2007: results of an incidence-based model
Arch Dermatol
Guidelines of care for the management of cutaneous squamous cell carcinoma
J Am Acad Dermatol
Sentinel lymph node biopsy for cutaneous squamous cell carcinoma on the head and neck
JAMA Otolaryngol Head Neck Surg
SLNB in cutaneous SCC: a review of the current state of literature and the direction for the future
J Surg Oncol
Histology of non-melanoma skin cancers: an update
Biomedicines
Quantifying direct DNA damage in the basal layer of skin exposed to UV radiation from sunbeds
Photochem Photobiol
Quantitative analysis of UV photolesions suggests that cyclobutane pyrimidine dimers produced in mouse skin by UVB are more mutagenic than those produced by UVC
Photochem Photobiol Sci
Occupational ultraviolet light exposure increases the risk for the development of cutaneous squamous cell carcinoma: a systematic review and meta-analysis
Br J Dermatol
Is ultraviolet exposure acquired at work the most important risk factor for cutaneous squamous cell carcinoma? Results of the population-based case-control study FB-181
Br J Dermatol
Occupational skin cancer induced by ultraviolet radiation and its prevention
Br J Dermatol
Biologically effective ultraviolet radiation: surface measurements in the United States, 1974 to 1985
Science
Cited by (0)
Disclosure Statement: No disclosures.